SEC Form 4 · accession 0001193125-26-303681
Tenaya Therapeutics, Inc. · TNYA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric J Hyllengren
Officer — Chief Financial Officer
Period of report
Jul 13, 2026
Accepted (ET)
Jul 14, 2026 · 9:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001858848
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F1 | $0.8365 | Jul 13, 2026 | A | 1,650,000 | A | Jul 13, 2027 | Jul 12, 2036 | Common Stock | 1,650,000 | 1,650,000 | D |
Explanation of responses
- F1Option granted pursuant to the Tenaya Therapeutics, Inc. 2024 Inducement Equity Incentive Plan. Option will vest as to 1/4th of the total number of shares subject to the option on the one-year anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested.